Sarepta Therapeutics Patents – Insights & Stats (Updated 2026)
Sarepta Therapeutics has a total of 1880 patents globally, out of which 812 have been granted. Of these 1880 patents, more than 63% patents are active. The United States of…
Sarepta Therapeutics has a total of 1880 patents globally, out of which 812 have been granted. Of these 1880 patents, more than 63% patents are active. The United States of…
Samsung Biologics has a total of 282 patents globally, out of which 135 have been granted. Of these 282 patents, more than 74% patents are active. Korea (South) is where…
Stealth BioTherapeutics has a total of 672 patents globally, out of which 225 have been granted. Of these 672 patents, more than 63% patents are active. The United States of…
Lightcast Discovery has a total of 296 patents globally, out of which 104 have been granted. Of these 296 patents, more than 78% patents are active. United States of America…
Regeneron has a total of 23419 patents globally, out of which 8198 have been granted. Of these 23419 patents, more than 91% patents are active. United States of America is…
Treeline Biosciences has a total of 115 patents globally, out of which all patents are application stage. Of these 115 patents, 93% patents are active. Taiwan is where Treeline Biosciences…
Pheon Therapeutics has a total of 52 patents globally, out of which 4 have been granted. Of these 52 patents, 75% patents are active. Europe (EPO) is where Pheon Therapeutics…
ENSEM Therapeutics has a total of 58 patents globally,out of which all are in application stage. Of these 58 patents, 91% patents are active. Taiwan is where ENSEM Therapeutics has…
Renew Biopharma has a total of 53 patents globally, out of which 23 have been granted. Of these 53 patents, 16% patents are active. The United States of America is…
Eikon Therapeutics has a total of 33 patents globally, out of which 4 have been granted. Of these 33 patents, more than 58% patents are active. United States of America…
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.
